Hospital Surgical Volume, Utilization, Costs and Outcomes of Retroperitoneal Lymph Node Dissection for Testis Cancer
Objectives. Retroperitoneal lymph node dissection (RPLND) outcomes for testis cancer originate mostly from single-center series. We characterized population-based utilization, costs, and outcomes and assessed whether higher volume affects outcomes. Methods and Materials. Using the US Nationwide Inp...
Saved in:
Main Authors: | Hua-yin Yu, Nathanael D. Hevelone, Sunil Patel, Stuart R. Lipsitz, Jim C. Hu |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2012-01-01
|
Series: | Advances in Urology |
Online Access: | http://dx.doi.org/10.1155/2012/189823 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Retroperitoneal Lymph Node Dissection as Primary Treatment for Metastatic Seminoma
by: Brian Hu, et al.
Published: (2018-01-01) -
A Review of Outcomes and Technique for the Robotic-Assisted Laparoscopic Retroperitoneal Lymph Node Dissection for Testicular Cancer
by: Zeyad R. Schwen, et al.
Published: (2018-01-01) -
Primary Retroperitoneal Approach to the Superior Mesenteric Vessels in Minimally Invasive Surgical Treatment of Right Colon Cancer with D3 Lymph Node Dissection. Technique and First Short-Term Outcomes
by: S. K. Efetov, et al.
Published: (2024-12-01) -
Robotic-Assisted Dissection of Bulky Lymph Nodes in Cervical Cancer
by: Ahmet Göçmen, et al.
Published: (2014-01-01) -
Sense and Nonsense of an Extended Pelvic Lymph Node Dissection in Prostate Cancer
by: Anthony Van Baelen, et al.
Published: (2012-01-01)